Skip to main content
. 2016 Dec 27;25(2):338–345. doi: 10.1002/oby.21726

Table 1.

Subject demographic and baseline characteristics

Parameter Usual care/NB + CLI
(N = 89)
NB + CLI (N = 153)
Age (y), mean (SD) 47.0 (9.98) 46.1 (9.66)
Sex, (% female) 86.5 81.7
Race (%)
White 71.9 81.0
Black or African American 27.0 18.3
Asian 0.0 0.7
American Indian or Alaska Native 1.1 0.0
Ethnicity (%)
Hispanic or Latino 5.6 2.6
Not Hispanic or Latino 94.4 97.4
Weight (kg), mean (SD) 100.2 (16.58) 101.4 (15.09)
BMI (kg/m2), mean (SD) 36.26 (4.36) 36.33 (4.20)
BMI category (%)
<30 kg/m2 5.6 2.0
<35 kg/m2 46.1 45.8
≥35 to <40 kg/m2 31.5 32.0
≥40 kg/m2 22.5 22.2
Waist circumference (cm), mean (SD) 111.9 (11.91) 112.2 (11.23)
Triglycerides (mg/dL), mean (SD) n = 86
114.8 (54.40)
n = 147
131.0 (70.09)
LDL cholesterol (mg/dL), mean (SD) n = 84
118.0 (26.17)
n = 147
115.5 (27.63)
HDL cholesterol (mg/dL), mean (SD) n = 84
50.4 (12.75)
n = 147
50.7 (11.38)
Glucose (mg/dL), mean (SD) n = 86
92.4 (11.46)
n = 147
89.7 (10.56)
Insulin (uIU/mL), mean (SD) n = 84
17.3 (10.68)
n = 147
19.5 (19.65)
HOMA‐IR, mean (SD) n = 84
4.07 (2.96)
n = 147
4.41 (5.01)
Systolic blood pressure (mm Hg), mean (SD) 120.6 (11.41) 123.7 (9.51)
Diastolic blood pressure (mm Hg), mean (SD) 78.8 (7.60) 80.4 (7.26)
Heart rate (bpm), mean (SD) 69.8 (8.68) 70.9 (8.66)

BMI, body mass index; CLI, comprehensive lifestyle intervention; HDL, high‐density lipoprotein; HOMA‐IR, homeostasis model assessment of insulin resistance; LDL, low‐density lipoprotein; NB, naltrexone/bupropion; SD, standard deviation.